Companies · Software / Tech
Alpharetta · Software / Tech · refined from filed group “Other Technology”
Diligence memoA one-page analyst read on QSpex Technologies Inc — recommendation, valuation, rhythm, risks.→QSpex Technologies Inc looks under-valued against its niche peers and is dormant on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the technology sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
QSpex Technologies Inc is one of 3920 Software / Tech companies tracked from Alpharetta. By capital raised it ranks among the largest (ahead of 95% of sector peers), and mid-pack by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 75%.
Round size and date are reported; the stage label is inferred from round size (latest is Series B — a $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the technology sector profile. Directional, not a quoted figure.
Benchmarked against 3920 companies in Software / Tech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 95% of sector peers (real $). Modeled value above 47% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #76 of 78.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| Orchid Labs Inc. | Series B | $40.6M | $1.1B | 1.89× |
| Overclock Labs, Inc. | Series B | $35.3M | $1.0B | 1.78× |
| Reflexis Systems Inc | Series B | $67.2M | $999.8M | 1.72× |
| Nav Technologies, Inc. | Series B | $67.8M | $995.5M | 1.71× |
| Vesper Technologies Inc. | Series B | $51.4M | $971.7M | 1.67× |
| Applied Data Finance, LLC | Series B | $30.8M | $938.7M | 1.61× |
| Digital Reasoning Systems, Inc. | Series B | $80.5M | $913.8M | 1.57× |
| Singular Labs Inc. | Series B | $35.6M | $913.7M | 1.57× |
| Skyport Systems, Inc. | Series B | $66.7M | $904.5M | 1.55× |
| Constellation Labs, LLC | Series B | $29.7M | $904.1M | 1.55× |
| Theta Labs, Inc. | Series B | $37.4M | $887.6M | 1.52× |
| SolidEnergy Systems Corp. | Series B | $79.5M | $879.4M | 1.51× |
| QSpex Technologies Inc this company | Series B | $90.2M | $30.5M | 0.05× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Series A | $12.0M | 2009-10-16 | $54.5M | $332.9M | 85% |
| Series A | $115K | 2010-06-25 | $523K | $3.2M | 85% |
| Series A | $6.0M | 2011-04-15 | $27.3M | $166.4M | 85% |
| Seed | $1.5M | 2012-03-01 | $7.5M | $51.1M | 85% |
| Series A | $3.0M | 2012-03-01 | $13.6M | $83.2M | 85% |
| Series A | $1.0M | 2012-05-02 | $4.5M | $27.7M | 85% |
| Series B | $20.5M | 2012-06-07 | $113.9M | $624.4M | 85% |
| Series B | $400K | 2012-10-05 | $2.2M | $12.2M | 85% |
| Series B | $8.0M | 2013-03-15 | $44.4M | $243.6M | 85% |
| Series A | $6.0M | 2013-03-15 | $27.3M | $166.4M | 85% |
| Seed | $3.0M | 2013-03-15 | $15.0M | $102.2M | 85% |
| Series B | $29.2M | 2013-10-11 | $162.1M | $888.5M | 85% |
| Series B | $34.5M | 2013-10-11 | $191.5M | $1.0B | 85% |
| Seed | $4.0M | 2013-10-11 | $20.0M | $136.3M | 85% |
| Seed | $2.0M | 2013-10-11 | $10.0M | $68.1M | 85% |
| Series A | $14.0M | 2013-10-11 | $63.6M | $388.4M | 85% |
| Seed | $1.1M | 2016-08-31 | $5.8M | $39.2M | 85% |
| Series B | $3.8M | 2016-08-31 | $20.8M | $114.2M | 90% |
| Series B | $1.0M | 2016-11-10 | $5.6M | $30.5M | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| Stephen Martin | — | 4 other | 2009-10 |
| Evan Melrose | — | 3 other | 2013-03 |
| Timothy McInerney | — | 3 other | 2013-10 |
| Martin P. Sutter | — | 1 other | 2009-10 |
| Martin Sutter | — | 1 other | 2013-03 |
| William Anton | — | 1 other | 2013-03 |
| Brett Craig | — | — | 2013-10 |
| Evan P. Melrose | — | — | 2012-06 |
| Glen Ellisor | — | — | 2013-03 |
| Glenn Ellisor | — | — | 2013-10 |
| Glen P. Ellisor | — | — | 2011-04 |
| James Grootegoed | — | — | 2013-03 |
| James P. Grootegoed | — | — | 2011-04 |
| John Lowery | — | — | 2013-03 |
| John Lowry | — | — | 2013-03 |
| John P. Lowery | — | — | 2012-06 |
| Kai P. Su | — | — | 2009-10 |
| Kai Su | — | — | 2013-03 |
| Karen Reid | — | — | 2013-10 |
| William P. Anton | — | — | 2011-04 |
QSpex Technologies Inc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| Message Systems, Inc. | Software / Tech | Series B | $77.7M | $36.5M | same sector · same stage |
| Pixxel Space Technologies, Inc. | Software / Tech | Series B | $68.0M | $32.7M | same sector · same stage |
| LIS Technologies Inc | Software / Tech | Series B | $64.5M | $28.7M | same sector · same stage |
| Prolacta Bioscience Inc | Biotechnology | Series B | $64.7M | $353.6M | network1 shared operator · same stage |
| Neovista Inc | Other Health Care | Series B | $63.3M | $114.9M | network1 shared operator · same stage |
| Redica Systems, Inc. | Software / Tech | Series B | $39.5M | $27.9M | same sector · same stage |
| Manhattan Pharmaceuticals Inc | Pharmaceuticals | Series B | $59.5M | $850.1M | network1 shared operator · same stage |
| Suneva Medical, Inc. | Healthtech | Series B | $140.2M | $24.9M | network1 shared operator · same stage |
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| Qualifi Technologies Inc | Software / Tech | Series A | $45.4M | 85% |
| QVINCI Software, LLC | Software / Tech | Series A | $138.7M | 84% |
| Qxm Solutions Inc | Other Technology | Pre-Seed | $9.8M | 83% |
| QED Labs, Inc. | Software / Tech | Seed | $43.9M | 83% |
| Qoins Technologies, Inc. | Software / Tech | Seed | $58.4M | 83% |
| QPoint, Inc. | Other Technology | Series A | $34.3M | 83% |
| Qdapp, Llc | Other Technology | Series A | $144.1M | 83% |
| Qwake Technologies, Inc. | Software / Tech | Series A | $101.2M | 83% |
See where QSpex Technologies Inc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at QSpex Technologies Inc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.